Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan

November 18, 2020 updated by: Jafir Hussain Shirazi, Islamia University of Bahawalpur
To assess the depression in adults especially in post COVID-19 duration in the rural and urban settings.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is designed to assess the prevalence of depression after the general and smart lockdown in various areas. This study includes both genders of any age.

Study Type

Observational

Enrollment (Actual)

390

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
      • Islamabad, Pakistan, 45320
        • Quaid-i-Azam University Islamabad
    • Punjab
      • Bahāwalpur, Punjab, Pakistan, 63100
        • The islamia university of Bahawalpur
      • Faisalabad, Punjab, Pakistan, 37150
        • GC University Faisalabad
      • Lahore, Punjab, Pakistan, 54000
        • University of Veterinary and Animal Sciences, Lahore
      • Multan, Punjab, Pakistan, 60800
        • Bahauddin Zakriya University Multan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Residents/ Visitors of the south punjab will be the study population of this study

Description

Inclusion Criteria:Any individual who can respond to the given questionnaire, with or without any ailment will be included in this study -

Exclusion Criteria:

Unconcious and non-cooperative individuals

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
single group
Respondents will be given survey form, filled and will be collected back
Other: service of questionnaire
Respondents will be given a survey form only and after filling this will be collected back

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence estimation of depression in adults
Time Frame: study will be completed in 15 days maximum
% prevalence of depression in adult population of south punjab will be assessed
study will be completed in 15 days maximum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Islamia University of Bahawalpur

Investigators

  • Principal Investigator: Jafir Shirazi, PhD, The islamia university of Bahawalpur

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

November 18, 2020

Study Completion (Actual)

November 18, 2020

Study Registration Dates

First Submitted

October 25, 2020

First Submitted That Met QC Criteria

October 25, 2020

First Posted (Actual)

October 27, 2020

Study Record Updates

Last Update Posted (Actual)

November 19, 2020

Last Update Submitted That Met QC Criteria

November 18, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • U1111-1260-1614

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe